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Using a pangenomic loss-of-function screening strategy, we have previously identified 76 potent mod-
ulators of paclitaxel responsiveness in non-small-cell lung cancer. The top hit isolated from this screen,
symplekin, is a well-established component of the mRNA polyadenylation machinery. Here, we performed
a high-resolution phenotypic analysis to reveal the mechanistic underpinnings by which symplekin de-
pletion collaborates with paclitaxel. We find that symplekin supports faithful mitosis by contributing to
the formation of a bipolar spindle apparatus. Depletion of symplekin attenuates microtubule polymer-
ization activity as well as expression of the critical microtubule polymerization protein CKAP5 (TOGp).
Depletion of additional members of the polyadenylation complex induces similar phenotypes, suggesting
that polyadenylation machinery is intimately coupled to microtubule function and thus mitotic spindle
formation. Importantly, tumor cells depleted of symplekin display reduced fecundity, but the mitotic
defects that we observe are not evident in immortalized cells. These results demonstrate a critical
connection between the polyadenylation machinery and mitosis and suggest that tumor cells have an
enhanced dependency on these components for spindle assembly.
Pangenomic loss-of-function screening is emerging as an
effective tool for revealing the components that support core
biological processes, including viral infection, DNA repair,
chemotherapeutic responsiveness, melanogenesis, and endocy-
tosis (5–7, 14, 18, 24, 28, 32, 45). A number of screening efforts
have focused on identifying those gene products that are re-
quired for mitotic progression in both the normal and the
tumorigenic settings (26, 27, 29, 30, 36, 45). These screens have
successfully returned validated mitotic participants but also
have isolated a diverse set of unanticipated genes whose en-
coded proteins have no previously described role in mitotic
progression but instead have well-established roles in pro-
cesses such as transcription (26, 27, 36, 45), RNA splicing and
translation (27, 36, 45), and vesicle transport (27), thereby
revealing an unexpected diversity in the compendium of gene
products supporting mitosis.
We have recently applied a genome-wide loss-of-function
paclitaxel synthetic-lethal strategy to identify cell-autonomous
specifiers of chemoresponsiveness in non-small-cell lung can-
cer (NSCLC) cells (45). This strategy returned a diverse set of
gene products, including symplekin (SYMPK), whose deple-
tion was the most potent for sensitizing NSCLC cells to a dose
of paclitaxel that has no detectable impact on cell viability.
Symplekin is a scaffold protein that supports the assembly of
polyadenylation machinery on nascent mRNA transcripts;
however, no role for symplekin in drug sensitivity or mitosis
has been reported (3). Polyadenylation is essential for the
maturation of most pre-mRNAs and regulates mRNA nuclear
export, stability, and translation (13, 33, 37). In Xenopus laevis
oocytes, the polyadenylation of specific meiotic transcripts is
regulated such that their activation occurs only following mei-
otic maturation signals (9, 20, 44). In mammalian cells, the
poly(A) tail length of specific transcripts changes in a cell
cycle-dependent manner (37), suggesting that cytoplasmic
polyadenylation is a conserved mechanism for exerting trans-
lational regulation of gene expression prior to and during cell
division.
Here, we have employed a high-resolution phenotypic anal-
ysis of symplekin to evaluate the contribution of polyadenyla-
tion machinery to mitotic control in the tumor and normal cell
settings. We find that symplekin is required to support bipolar
spindle formation in multiple NSCLC-derived tumor cells and
that symplekin depletion impairs proliferation of NSCLC cells
in vivo. The basis of symplekin’s contribution to mitotic pro-
gression appears to be at the level of microtubule function and
expression of a critical component of the microtubule polymer-
ization machinery, CKAP5 (TOGp). Depletion of other poly-
adenylation components causes similar alterations in CKAP5
expression and mitotic progression. Therefore, our results
demonstrate that mitotic fidelity is acutely sensitive to pertur-
bations of polyadenylation machinery and suggest that inhibi-
tion of polyadenylation may synergize with current antimitotic
agents.
MATERIALS AND METHODS
Cell culture. H1155, H1299, HCC366, and HCC515 cells were a gift from John
Minna. All cell lines had recently been genotyped using short tandem repeat
(STR) analysis. Cells were maintained in RPMI medium (Gibco) with 5% fetal
bovine serum (FBS) as described previously (45). BJ fibroblasts immortalized
with human telomerase reverse transcriptase (hTERT) were a gift from Fred
Grinnell (UT-Southwestern). BJ cells were maintained in Dulbecco modified
Eagle medium (DMEM) plus 10% FBS.
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Cell Titer Glo assays. Cell Titer Glo assays were performed using independent
small interfering RNAs (siRNAs) from the siGENOME Smart pool targeting
symplekin as previously described (45).
siRNA transfections. Transfections were performed as described previously
(45) with siGENOME Smart pools (ThermoFisher). Cells were transfected for
either 72 or 96 h as indicated in the figure legends. As a control, either a
mismatch siRNA or an siRNA targeting DLNB14, which has no detectable
impact in our assay system, was used. Sequences for all siRNAs utilized can be
viewed in Table S1 in the supplemental material.
High-content imaging. H1155 green fluorescent protein (GFP)-histone 2B-
expressing cells were obtained by retroviral transduction. Retrovirus was pro-
duced by Fugene (Roche) transfection of 293gp cells with pCLNCX-GFP-H2B
(a gift from Gray Pearson, UT-Southwestern) and vesicular stomatitis virus G
protein (VSV-G), and virus was harvested at 48 h posttransfection. H1155 cells
at 50% confluence were transduced with virus in 4 g/ml Polybrene, and stably
expressing cells were selected using 600 g/ml Geneticin (Gibco). For imaging,
cells were reverse transfected with the indicated siRNAs, plated in a 96-well
format, and exposed to paclitaxel at 48 h posttransfection. Twenty-four hours
post-paclitaxel treatment, the cells were imaged on a BD Pathway 855 bioimager
using a 40 or 20 high-numerical-aperture (high-NA) objective. Images were
taken every 15 min for the next 48 h, and an image sequence was generated using
ImageJ (39). Manual quantification was used for the indicated parameters.
Flow cytometry. H1155 cells were fixed in 50% ethanol–phosphate-buffered
saline (PBS), washed, and resuspended in propidium iodine (BD) for 30 min. A
minimum of 10,000 cells were collected for each condition by Summit 4.3
(Dako), and cell cycle distribution was determined using the ModFit software
package (Verity Software House).
Lentivirus production. Short hairpin RNA (shRNA) clones in the PLKO1
vector were obtained from the RNAi Consortium (Open Biosystems). Lentivirus
targeting SYMPK was produced by Fugene-mediated transfection of 293T cells
with plasmids for VSV-G, 8.9, and shRNAs targeting SYMPK or GFP
(SYMPK clones TRCN0000141511 and TRCN0000144902 were effective). Virus
was harvested at 48 h posttransfection and used to infect cells at 50% confluence
in conjunction with 5 g/l Polybrene. Infection rates based on GFP assays
performed in parallel were over 90%.
Quantitative real-time RT-PCR. Total RNA was collected from H1299 cells
using the GenElute Mammalian Total RNA Miniprep kit (Sigma). cDNA was
synthesized from 2 g total RNA using the High-Capacity cDNA reverse
transcription kit (Applied Biosystems). Real-time reverse transcription-PCR
(RT-PCR) used inventoried TaqMan gene expression assays designed to
detect mRNA exclusively and the 7500 Fast real-time PCR system (Applied
Biosystems). Actin or glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was used as the endogenous control, and cells transfected with control siRNA
were used for calculating differences in expression by the threshold cycle
(2CT) method. For CKAP5 levels following SYMPK reduction, results are
from pooling of results from 3 individual experiments performed in duplicate
in which the average endogenous control CT values between conditions never
varied more than 0.3. For measurement of transcript knockdown, experi-
ments were performed in triplicate with CT values between conditions never
varying more than 0.6.
Immunoblotting. Cells were lysed directly in boiling sample buffer (100 mM
Tris-Cl, 4% SDS, 20% glycerol, 0.2% bromophenol blue), subjected to SDS-
polyacrylamide gel electrophoresis, and transferred to an Immobilon polyvinyl-
idene difluoride membrane (Sigma). For MG-132 experiments, 20 M MG-132
(Sigma) was added for 12 h prior to harvesting. Primary antibodies used include
anti-SYMPK (BD Biosciences), anti-GAPDH (Santa Cruz), anti-cyclin B1 (Cell
Signaling), anti-TACC3 (Santa Cruz), anti-CKAP5 (Abcam), anti-CSTF2 (Ab-
cam), anti-CPSF1 (Santa Cruz), and anti-CPSF3 (Santa Cruz). Secondary anti-
bodies used include peroxidase-conjugated anti-mouse and anti-rabbit IgG
(Jackson ImmunoResearch). Densitometry analysis was performed in ImageJ.
Immunofluorescence. Cells were grown on glass coverslips and fixed at 72 or
96 h posttransfection in 3.7% formaldehyde. Cell were processed for immuno-
fluorescence as described previously (45, 46). To visualize centrosomal proteins
(CKAP5, TACC3, c-NAP1, rootletin, and NUMA1), cells were extracted with
0.5% Triton for 30 s, prior to fixation in cold methanol. Primary antibodies used
include anti--tubulin (Sigma), pericentrin (Abcam), rootletin (Santa Cruz),
Aurora-A (Sigma), Ncd80 (Abcam), TACC3 (BioLegend), NUMA1 (Novus),
and CKAP5 (Abcam). After washes in PBS containing 0.1% Tween 20 and 10
mg/ml bovine serum albumin (PBTA), slips were placed in Alexa Fluor-conju-
gated secondary antibody (Invitrogen). Slides were imaged on an Axioimager
upright microscope (Zeiss) equipped with a charge-coupled device (CCD)
camera.
Microtubule regrowth assay. H1299 cells were treated with 11 M nocodazole
(Calbiochem) at 96 h posttransfection. After 2 h of treatment, cells were placed
in fresh medium and allowed to recover for the indicated time period. Cells were
washed in PHEM buffer {60 mM PIPES [piperazine-N,N-bis(2-ethanesulfonic
acid)], 25 mM HEPES, 10 mM EGTA, 2.0 mM MgCl2, 1.0 M paclitaxel}, and
depolymerized tubulin was extracted with 0.2% Triton in PHEM buffer for 1 min.
Extracted cells were washed in 1 PBS and fixed in 3.7% formaldehyde for 15
min. An immunofluorescence assay for -tubulin and pericentrin was performed
after permeabilization in 0.5% Triton and blocking in PBTA. Quantification of
mean -tubulin fluorescence intensity in the region of the centrosome was
measured in ImageJ. For the measurement, pericentrin staining was used to
identify the centrosomes of each cell and a circle of constant diameter across all
samples was drawn around the centrosome to measure the intensity of the
-tubulin fibers emanating from the centrosome. ImageJ was utilized to measure
the -tubulin fluorescence in the circle with a minimum of 40 cells per treatment
group.
Tumor xenografts. H1299 cells stably expressing luciferin (H1299_luc) were a
gift from John Minna (UT-Southwestern). H1299_luc cells were transduced with
lentivirus targeting shGFP or SYMPK, and viable cells were harvested at 5 days
postinfection for injection into nude mice. Two million cells/mouse were injected
subcutaneously in the right flank, and mice were treated with 10 l/gram luciferin
and imaged biweekly with bioluminescent imaging (BLI) (34) until tumor devel-
opment. Tumor growth was thereafter monitored biweekly by BLI. Tumor vol-
ume was calculated as length  width2  0.5 from BLI measurements. All
animals were treated in accordance with Institutional Animal Care and Use
Committee (IACUC) guidelines instituted at The University of North Carolina
at Chapel Hill.
RESULTS
Symplekin is required for mitotic spindle integrity. Symple-
kin was originally identified as a statistically significant modu-
lator of paclitaxel sensitivity by using a high-throughput che-
mosensitizer screening platform. Thus, we first validated
symplekin for off-target consequences by verifying that multi-
ple independent siRNA sequences were capable of inducing
synthetic lethality (Fig. 1A). In addition, we validated that
symplekin protein levels were depleted (Fig. 1A). Because we
have previously observed that RNA interference (RNAi) pa-
clitaxel sensitizer screens can return components whose deple-
tion induces a mitotic arrest (45), we evaluated the integrity of
the mitotic spindle in symplekin-depleted H1155 cells treated
with 10 nM paclitaxel. As observed for other targets identified
by our whole-genome screening effort, symplekin depletion led
to an increase in the accumulation of mitotic figures (Fig. 1B).
This accumulation was also detected at the population level by
flow cytometry, which revealed a marked increase in 4N DNA
content of symplekin-depleted cells exposed to 10 nM pacli-
taxel compared to that of control-transfected cells (Fig. 1C).
Immunoblot analysis revealed elevated levels of cyclin B1, a
substrate of the anaphase-promoting complex (APC), the E3
ligase whose activity is restricted in the presence of improper
chromosome alignment (Fig. 1D). Thus, the observed accumu-
lation of mitotic cells in the symplekin-depleted samples could
indicate an aberrant mitosis. Indeed, symplekin-depleted
H1155 cells exposed to 10 nM paclitaxel displayed a high
frequency of multipolar spindles characterized by disorganized
tubulin and multiple centrosomes compared to the structure of
control-transfected cells (Fig. 1E). These data suggest that
symplekin function is directly coupled to the ability of cells to
form a normal bipolar spindle.
Symplekin is required for high-fidelity mitosis. Given our
observations that symplekin contributes to bipolar spindle for-
mation, we directly assessed the consequence of symplekin
depletion on mitotic progression in real time by live imaging of
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H1155 cells stably expressing the chromatin marker GFP-H2B.
By performing single-cell lineage tracing, we measured both
the length and outcome of mitosis in symplekin- and control
siRNA-transfected cells (Fig. 2). As expected, control or
symplekin depletion alone had little effect on either mitotic
fate or mitotic timing (Fig. 2A and B). However, symplekin-
depleted cells exposed to 10 nM paclitaxel exhibited a signifi-
cantly prolonged mitosis compared to those of control-trans-
fected and paclitaxel-treated cells (Fig. 2B). The outcome of
this prolonged mitosis was aberrant in 75% of the individual
cells studied. In particular, instead of the formation of 2 daugh-
ter cells, symplekin-depleted samples underwent either apop-
tosis, micronucleation, or a multipolar mitosis following
mitotic arrest (Fig. 2A and C). Taken together, these observa-
tions suggest that symplekin supports mitotic spindle forma-
tion and mitotic progression in NSCLC cells.
Symplekin is necessary for mitosis in diverse NSCLC ge-
netic settings. To determine if the impacts of symplekin are
unique to H1155 cells or represent a common mechanism
observed across diverse genetic backgrounds, we assayed mi-
totic defects following symplekin depletion in H1299 cells,
which were derived from an NSCLC lymph node metastasis.
H1299 cells undergo a mitotic arrest followed by bypass of an
activated APC and form micronucleated daughter cells when
exposed to doses of paclitaxel of 10 nM and greater. Similar to
the synthetic lethality seen in H1155 cells, H1299 cells depleted
of symplekin and exposed to 10 nM paclitaxel displayed an
increase in the frequency of micro- and multinucleated cells
compared to that of the control (Fig. 3A). We do not observe
the same effects in the normal-tissue-derived human bronchial
epithelial cell line HBEC3 (Fig. 3B).
We next sought to determine the impacts of prolonged sup-
pression of symplekin expression in NSCLC cells. To this end,
we stably repressed symplekin expression in H1299 cells by
using an shRNA-mediated system where we pooled two effec-
tive shRNAs targeting symplekin (Fig. 3C). Stably repressing
symplekin expression in the H1299 NSCLC cell line led to an
increase in micronucleation in the absence of paclitaxel (Fig.
3C). In our original screening cell line, H1155, stable repres-
sion of symplekin led to an increase in mitotic figures in the
absence of paclitaxel (Fig. 3D). Extending this analysis to two
additional NSCLC cell lines and immortalized BJ fibroblasts
FIG. 1. SYMPK is required for mitotic spindle integrity after exposure to paclitaxel (Pac). (A) Whole-cell extracts of H1155 cells
transfected with indicated siRNAs were immunoblotted to detect endogenous SYMPK (left panel). Viability assay in H1155 cells transfected
with control or independent siRNAs targeting SYMPK. Error bars represent standard errors of the means (n  2). (B) H1155 cells
transfected with the indicated siRNAs and exposed to paclitaxel for 24 h were stained with 4,6-diamidino-2-phenylindole (DAPI) to detect
mitotic cells. Error bars represent standard deviations (n  2). (C) H1155 cells were transfected with indicated siRNAs, and at 48 h
posttransfection, cells were exposed to paclitaxel for 24 h. Cells were then fixed and stained with propidium iodide. A representative
fluorescence-activated cell sorting profile of propidium iodide intensity is shown. (D) Whole-cell lysates of H1155 cells transfected with
indicated siRNAs for 48 h and then exposed to paclitaxel for an additional 24 h were immunoblotted for cyclin B1. (E) H1155 cells
transfected with indicated siRNAs for 48 h and then exposed to paclitaxel for 24 h were fixed and stained with -tubulin (green), pericentrin
(red), and DAPI. Cells were scored as having 2 centrosomes if there were more than 2 pericentrin-positive poles during mitosis. Error bars
represent standard deviations (n  3). All P values were calculated using a Student t test.
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revealed that the generation of micronucleated cells following
prolonged symplekin depletion is a common phenomenon in
NSCLC cells but not in normal diploid fibroblasts immortal-
ized with hTERT (Fig. 3D). Thus, while the transient impacts
of symplekin depletion are observable only in the presence of
a microtubule-disrupting agent, prolonged symplekin deple-
tion alone increases the frequency of aberrant mitosis and
mitotic arrest in tumor cells but not normal cells.
Loss of symplekin impairs tumor formation in a mouse
xenograft model. To directly test if the mitotic dysfunction that
we observe in multiple NSCLC cell backgrounds could result in
reduced neoplastic potential, we evaluated the ability of H1299
cells stably depleted of symplekin to form xenograft tumors in
nude mice. Luciferase-expressing H1299 cells were injected
into nude mice 5 days following infection with shRNAs target-
ing symplekin or GFP. Tumor development was monitored for
4 weeks by twice-weekly imaging of tumors. While 100% of
control-infected cells formed subcutaneous tumors, only 50%
of mice injected with symplekin-depleted cells established tu-
mors (Fig. 4A). Furthermore, at 5 weeks postinjection, the
symplekin hairpin tumors were significantly smaller than those
in control cells (Fig. 4B), suggesting that the asymmetric divi-
sions that we observe in vitro may accumulate over time to
reduce tumor cell fecundity.
Symplekin modulates microtubule polymerization. The for-
mation of a normal, bipolar spindle apparatus is exquisitely
dependent on proper microtubule function, which is signifi-
cantly altered in the presence of chemotherapeutic drugs such
as paclitaxel (23). Given the symplekin-paclitaxel synthetic-
lethal phenotype that we observed in NSCLC cells, we probed
microtubule polymerization efficiency in H1299 cells following
transient depletion of symplekin by using a microtubule re-
growth assay. Here, H1299 cells transfected with control or
symplekin siRNAs were exposed to a high dose of nocodazole
to induce microtubule depolymerization. Microtubules were
depolymerized to similar degrees in both control- and symple-
kin-transfected samples (Fig. 5A and B). However, after 10
min of recovery, symplekin-depleted cells displayed little mi-
FIG. 2. SYMPK is required for high-fidelity mitotic progression in tumor cells. (A) H1155 cells expressing GFP-histone H2B were transfected
with indicated siRNAs. At 48 h posttransfection, cells were exposed to 10 nM paclitaxel or carrier and imaged by live time-lapse microscopy from
24 to 72 h post-paclitaxel treatment. Single-cell lineage tracing was performed to identify the mitotic exit phenotype for a total of 48 cells per
condition. (B) Quartile ranges for time in division as calculated from chromosome condensation to anaphase onset in 48 cells under the conditions
described for panel A. P values were calculated with the Mann-Whitney test. (C) Fold increase in abnormal mitotic exits in 10 nM paclitaxel for
control- or SYMPK-depleted cells across 3 independent live-cell imaging experiments. The data represent the fates of at least 145 individual cells
for each treatment. Error bars represent standard deviations.
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crotubule regrowth from their centrosomes. A similar trend
was observed in mitotic cells, where growth of microtubules
from both the spindle poles and the kinetochores was signifi-
cantly attenuated in symplekin-depleted samples (Fig. 5A and
B). Thus, depletion of symplekin significantly alters microtu-
bule polymerization, a process that is essential for normal
spindle formation.
CKAP5 expression is sensitive to depletion of symplekin.
Symplekin is a multifunctional protein implicated in transcrip-
tion and translation as well as signaling at tight junctions (3, 21,
25, 43). The localization pattern of symplekin has previously
been described at the tight junctions and in the nucleus (25),
the latter of which is a pattern that we also observe in H1299
cells (see Fig. S1A in the supplemental material). During mi-
tosis, symplekin is distributed diffusely throughout the nucleo-
plasm and does not appear to localize to a specific mitotic
structure at the microscopic resolution employed in this study
(Fig. S1A), suggesting that symplekin does not impact mitosis
through a direct association with the mitotic machinery. Given
the role of symplekin in gene expression (8, 21, 38) and the
errors observed in spindle integrity, mitotic progression, and
microtubule nucleation, we hypothesized that symplekin could
be impacting expression of proteins required for mitotic spin-
dle formation. To assess this possibility, we performed a func-
tional analysis of a panel of proteins required for proper cen-
trosomal maturation and microtubule nucleation (1, 4, 10, 15,
FIG. 3. SYMPK is necessary for mitosis in tumor cells from multiple genetic backgrounds. (A) H1299 cells were transfected with the indicated
siRNAs for 48 h followed by exposure to paclitaxel for 24 h. Cells were fixed and stained with -tubulin and DAPI (left panel), followed by quantification
of micro- and multinucleated cells (right panel). Error bars represent standard deviations (n  3). (B) Immortalized HBEC3 cells were transfected with
the indicated siRNAs for 48 h followed by exposure to paclitaxel for 24 h. A quantification of micro- and multinucleated cells is shown. Error bars
represent standard deviations (n  3). (C) H1299 cells were infected with lentivirus harboring control (GFP) or SYMPK shRNAs, and at 5 days
postinfection, cells were fixed and stained with -tubulin and DAPI followed by quantification of micro- and multinucleated cells. Error bars represent
standard deviations (n  3). (D) H1155 cells were treated as described for panel C. Representative images (left panel) and quantification of percentages
of total cells in mitosis (right panel) are shown. Error bars represent standard deviations (n  3). (E) HCC515, HCC366, and BJ fibroblasts were treated
as in panel B, except that cells were fixed 7 days postinfection. Cells were costained with -tubulin/DAPI and scored microscopically for micronucleation.
Error bars represent standard deviations (n  3). All P values were calculated using a Student t test.
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17, 19, 47, 48). Symplekin depletion alone had no detectable
effect on the localization and expression of almost all proteins
studied (Fig. S1B). However, symplekin depletion had a pro-
found effect on the expression of CKAP5 as detected by both
immunofluorescence (Fig. 6A) and immunoblot analysis (Fig.
6B and C). CKAP5 displays an elevated expression pattern in
tumor cells (11) and localizes to the centrosome, where it is
thought to enhance microtubule polymerization and nucle-
ation (12, 22). CKAP5 depletion significantly decreases the
viability of H1155 and H1299 cells (Fig. S2A). This effect is
likely due to the potent impact of CKAP5 on microtubule
polymerization and stability in H1299 and other cell types (Fig.
S2B) (16, 19, 31).
Given symplekin’s role in transcription and translation, we
evaluated CKAP5 transcript levels in symplekin-depleted cells.
Symplekin depletion did not affect the level of CKAP5 mRNA,
suggesting a posttranscriptional mode of regulation (Fig. 6D).
To determine whether the effects on CKAP5 were mediated by
increased degradation, we evaluated CKAP5 protein levels in
symplekin-depleted cells exposed to the proteosome inhibitor
MG-132. CKAP5 levels were globally increased in MG-132-
treated cells; however, proteasome inhibition was not sufficient
to rescue the reduced CKAP5 levels observed in symplekin-
depleted cells (Fig. 6E). Since CKAP5 stabilizes microtubules
primarily by opposing the depolymerizing activity of mitotic
centromere-associated kinesin (MCAK), we evaluated the im-
pact of codepletion of SYMPK and MCAK on the microtubule
network. In H1299 cells, MCAK depletion impairs microtu-
bule depolymerization by nocodazole, as has previously been
reported (2). Importantly, codepletion of MCAK and SYMPK
results in the depolymerization of microtubules in the presence
of nocodazole (Fig. 6F).
Multiple polyadenylation components collaborate with pa-
clitaxel. Symplekin is a core component of the polyadenylation
machinery, which has recently been implicated in regulating
mitotic progression through phase-specific changes in poly(A)
tail length (37). To determine if attenuation of the polyade-
nylation complex in general can collaborate with paclitaxel, we
retrospectively examined the impact of the 14 core polyade-
nylation proteins in our original genome-wide paclitaxel sen-
sitivity screen (45). In addition to symplekin, depletion of the
polyadenylation proteins CPSF1, CSTF2, and CPSF3 all en-
hanced paclitaxel sensitivity to some degree in our primary
FIG. 4. Depletion of SYMPK impairs tumor growth in vivo.
(A) Two million luciferase-expressing H1299 cells infected with lenti-
virus harboring control or SYMPK shRNAs were injected in the right
flank of Harlan nude mice. The picture shows bioluminescence imag-
ing of a representative tumor burden at 35 days postinjection. (B) Mice
in panel A were subjected to BLI twice weekly following injection of
H1299 cells. A line graph of growth curves for indicated groups is
shown. Error bars represent standard errors of the means for 10 mice
in each group.
FIG. 5. Depletion of SYMPK reduces microtubule stability.
(A) H1299 cells transfected with indicated siRNAs for 96 h were
treated with 11 M nocodazole for 2 h. Cells were fixed at 0 and 10 min
post-nocodazole washout and stained with -tubulin (green), pericen-
trin (red), and DAPI. A representative image (left panel) of interphase
cells at 0 and 10 min postrecovery and box plot quantification of
fluorescence intensity (right panel) are shown. The box plot was de-
rived from quantifying a minimum of 75 interphase cells per condition
across 8 independent fields of view. (B) Microtubule recovery in mi-
totic cells under the conditions described previously. A representative
image (left panel) of mitotic cells and a box plot quantification of
fluorescence intensity (right panel) are shown. The box plot was de-
rived from quantifying a minimum of 45 mitotic cells per condition. All
P values were calculated by the Mann-Whitney test.
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screen. In H1299 cells, depletion of both CPSF1 and CPSF3
reduced CKAP5 protein levels as detected by immunoblot
analysis (Fig. 7A), suggesting that CKAP5 expression is exquis-
itely sensitive to perturbations of the polyadenylation complex.
However, the sensitization observed with CSTF2 is uncoupled
from the CKAP5 phenotype. Additionally, H1299 cells de-
pleted of CSTF2, CPSF1, or CPSF3 and exposed to paclitaxel
demonstrated a significant increase in the occurrence of multi-
and micronucleated cells (Fig. 7B). To determine if these sub-
units impacted mitotic progression in a manner similar to that
of symplekin, we employed our time-lapse imaging system in
H1155 GFP-H2B cells to evaluate mitotic outcomes. As with
symplekin, CPSF1, CPSF3, and CSTF2 depletion increased the
frequency of abnormal mitotic exits (Fig. 7C). Surprisingly,
CSTF2 depletion exhibited a higher prevalence of multipolar
divisions than did depletion of the other components. Thus,
FIG. 6. SYMPK depletion leads to loss of CKAP5. (A) H1299 cells transfected with indicated siRNAs were fixed at 80 h posttransfection and
immunostained for CKAP5 (red), Aurora-A (green), and DAPI. (B) Whole-cell lysates from H1299 cells transfected with indicated siRNAs for
96 h were immunoblotted to assess CKAP5 expression. TACC3 is included as a control for effects on global protein expression following transient
depletion. (C) H1299 cells harboring lentivirus from control or two independent SYMPK-targeting shRNAs were blotted for CKAP5 expression
at 9 days postinfection. (D) Quantitative PCR analysis of CKAP5 mRNA levels in H1299 cells depleted of SYMPK at 96 h posttransfection. Error
bars represent standard deviations (n  4 biological replicates). (E) Whole-cell lysates of H1299 cells transfected with indicated siRNAs for 96 h
and exposed to vehicle or MG-132 for 14 h were immunoblotted for CKAP5 expression (left panel). The graph (right panel) depicts densitometry
analysis with error bars representing standard errors of the means from 2 biological replicates. DMSO, dimethyl sulfoxide. (F) H1299 cells were
transfected with the indicated siRNAs for 96 h followed by depolymerization of microtubules with 11 M nocodazole for 2 h. Representative
images at 0 min of recovery (top left panel) and quantification of a minimum of 120 cells from a representative experiment (bottom left panel)
are shown. Gene knockdown was confirmed by RT-PCR (right panel) with error bars representing standard errors of the means from triplicate
analysis.
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altered expression of multiple polyadenylation components has
acute effects on mitotic fidelity.
DISCUSSION
We have uncovered an intimate functional connection be-
tween polyadenylation machinery and the formation of a bi-
polar spindle needed for accurate segregation of chromo-
somes. These mitotic defects are due, at least in part, to
attenuation of the microtubule polymerization machinery and
loss of microtubule dynamicity, which is essential for chromo-
some capture and alignment. The observation that depletion of
multiple components of the polyadenylation complex leads to
mitotic defects demonstrates an unanticipated and critical con-
tribution of this complex to mitotic progression by supporting
microtubule dynamics. This selectivity is a bit surprising since
polyadenylation is likely an essential housekeeping process
required for many biological processes. However, hypomor-
phic analyses, such as RNAi, allow us to uncover processes that
are most vulnerable to alterations of a given housekeeping
function. Our results, taken together with the identification of
symplekin as the most statistically significant sensitizer to pa-
clitaxel in the genome, suggest that polyadenylation machinery
is tightly coupled to mitotic progression.
In particular, we find that the protein expression level of a
critical mitotic component, CKAP5, is sensitive to depletion of
polyadenylation machinery. While we have not yet determined
if CKAP5 protein expression can be directly regulated by poly-
adenylation, we find that symplekin depletion does not appear
to affect CKAP5 transcript abundance or protein turnover.
Thus, the changes that we observe in CKAP5 protein expres-
sion could be due to an alteration in translation initiation or
mRNA stability, which could be a direct result of the depletion
of key polyadenylation components. Alternatively, perturba-
tions in polyadenylation machinery, which may be impacting a
large set of transcripts (37), could alter endogenous mecha-
nisms that regulate CKAP5 protein levels. In either case, we
have revealed that mitotic integrity, microtubule dynamics, and
CKAP5 levels are sensitive to alterations in the polyadenyla-
tion machinery.
An emerging paradigm is that polyadenylation may play an
important role in tumorigenesis. Most transcripts have alter-
native polyadenylation (APA) sites, which allow for regulation
of the 3 untranslated region (UTR) length. APA has been
correlated with proliferation, as activation of T cells induces a
global shortening of 3 UTRs (40), and with tumorigenesis,
where truncation of the 3 UTR is widespread, potentially
conferring resistance to microRNA (miRNA)-mediated silenc-
ing to support oncogenic phenotypes (35, 42). In addition,
symplekin expression in lung and colon cancer cells is elevated
compared to that in normal cells, indicating that an upregula-
tion of polyadenylation machinery could be a frequent event
FIG. 7. Polyadenylation is required for CKAP5 expression and faithful mitosis. (A) Whole-cell lysates from H1299 cells transfected with
indicated siRNAs for 96 h were immunoblotted for CKAP5 expression. (B) H1299 cells were transfected with the indicated siRNAs for 48 h
followed by exposure to paclitaxel for an additional 24 h. Cells were stained for -tubulin and DAPI followed by quantification of multi- and
micronucleated cells. Error bars represent standard deviations (n  3). (C) H1155 GFP-H2B cells were transfected with the indicated siRNAs to
mediate gene knockdown (left panel), treated with 10 nM paclitaxel, and imaged under the conditions described previously. The radar plot (right
panel) depicts mitotic exit phenotypes with each line indicating a 10% increase in exit type. Results are from a minimum of 50 cells per condition.
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during tumorigenesis (8, 41). Our findings that symplekin de-
pletion induces mitotic defects in tumor cells, but not in nor-
mal cells, suggest that the demand for cell division in tumor
cells may heighten the dependency on polyadenylation ma-
chinery to maintain the molecular framework that supports
mitosis. Collectively, these results suggest that polyadenylation
may be an acquired vulnerability in tumor cells. Our results
indicate that this pressure point may be best observed and
exploited through combinatorial targeting of mitosis. Antimi-
totics, such as paclitaxel, are first-line chemotherapeutics
whose effectiveness is limited by significant toxicity and ac-
quired resistance. Thus, therapeutic regimens that combine
antimitotics with polyadenylation inhibitors may have an en-
hanced effectiveness for cytotoxicity in tumor cells while de-
creasing adverse events in normal tissues.
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